March 2018

 

Issue

Supplement

GUEST CHIEF MEDICAL EDITORS’ PAGE

Abdominal Aortic Approaches

By Daniel G. Clair, MD; and Timothy A. Resch, MD, PhD

COVER STORIES

What Constitutes a Compromised Aortic Neck in 2018?

Anatomic risk factors associated with an increased risk of proximal seal failure with standard EVAR in the era of device and technique advancement.

By Graeme McFarland, MD; and Jason T. Lee, MD

Nonfenestrated Options for Treating Compromised AAA Necks

How to overcome juxtarenal AAAs.

By Cornelis G. Vos, MD, PhD; Richte C.L. Schuurmann, MSc; and Jean-Paul P.M. de Vries, MD, PhD

Fenestrated Options for Treating Compromised AAA Necks

An overview of today’s available devices to overcome a hostile neck.

By Salma El Batti, MD, PhD; Anna Prent, MD, FEBVS; and Tara M. Mastracci, MD, MSc, FRCSC, FACS, FRCS

Ask the Experts: Does Treating Type II Endoleak and the Aneurysm Sac Make a Difference?

With Naiem Nassiri, MD, RPVI; Alan Dardik, MD, PhD; Hence J.M. Verhagen, MD, PhD; Stéphan Haulon, MD, PhD; Claire Watkins, MD; Dominique Fabre, MD; and Gustavo S. Oderich, MD

Choosing the Right Option for Treating EVAR Failure: When to Use and Avoid Endovascular Options

A review of the various indications for reintervening after infrarenal EVAR and the technical options available.

By Nuno V. Dias, MD, PhD; Björn Sonesson, MD, PhD; and Tim Resch, MD, PhD

Choosing the Right Option for Treating EVAR Failure: When to Use and Avoid Open Repair

A discussion of patient selection and when open repair should be considered based on the type of endoleak and presence of infection.

By Zachary M. Arthurs, MD

Long-Term Outcomes of EVAR Trials: How Do We Reconcile the Differences?

Prof. Jan Blankensteijn compares the results from the EVAR 1 and DREAM trials and discusses possible shortcomings of these data and the path ahead for future investigation.

With Jan Blankensteijn, MD, PhD

The Roles of Open and Endovascular Repair in Aortic Infection

A review of the approach to treatment for primary and secondary aortic infections.

By Anders Wanhainen, MD, PhD; Karl Sörelius, MD, PhD; Hamid Gavali; and Kevin Mani, MD, PhD

FEATURED TECHNOLOGY

Sponsored by Endologix

The Ovation Abdominal Stent Graft Creates a Patient-Specific EVAR Seal in a Variety of Anatomies

With Salem M. George Jr, MD, FACS; Venkatesh Ramaiah, MD, FACS; and Matt Thompson, MD, FRCS

EUROPEAN FEATURED TECHNOLOGY

Sponsored by Cordis, a Cardinal Health company

S.M.A.R.T.® Flex Vascular Stent System: Two-Year Experience in Treating Femoropopliteal Lesions

By Enrico Maria Marone, MD

SUPERFICIAL VENOUS DISEASE

Key Developments in Superficial Venous Disease Management

A rundown of five significant advancements seen in the past year for the treatment and management of superficial venous disease.

By Raghu Kolluri, MD, RVT, RPVI; and Brian Fowler, BS, RVT

Predicting and Preventing Varicose Vein Recurrence

Evaluating the data to better predict and prevent varicose vein recurrence.

By Sergio Gianesini, MD, PhD

Ask the Experts: Which Forces Most Drive Platform Adoption in Superficial Venous Care?

A panel discusses how they navigate the technologies available for treating superficial venous disease and the factors that influence widespread adoption.

With Julianne Stoughton, MD, FACS; Thomas Proebstle, MD; Neil Khilnani, MD, FSIR, FACPh; and Steve Elias, MD, FACS, FACPh

DEPARTMENTS

Innovations

An Interview With Daniela Branzan, MD

Dr. Branzan discusses various technical aspects of current approaches to TAAA repair, her belief in multidisciplinary cooperation, and the advancements she hopes to see during her career in vascular medicine.

 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.